Fortress Biotech Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights

NEXT STORY
Curetis Retains H.C. Wainwright & Co. as Strategic Advisor
PREV STORY
Stemline Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Saniona Announces Oral Presentation of Tesomet Data in Hypothalamic Obesity at ENDO 2021

author_avatar
NASDAQ Market News

The continuing medical education market is expected to grow at a CAGR of approximately 7% during 2021-2026

author_avatar
NASDAQ Market News

U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test

author_avatar
NASDAQ Market News